CH415663A - Verfahren zur Herstellung neuer Ester von substituierten, sekundären oder tertiären Aralkylamino-alkoholen mit substituierter Benzoesäure - Google Patents
Verfahren zur Herstellung neuer Ester von substituierten, sekundären oder tertiären Aralkylamino-alkoholen mit substituierter BenzoesäureInfo
- Publication number
- CH415663A CH415663A CH1310663A CH1310663A CH415663A CH 415663 A CH415663 A CH 415663A CH 1310663 A CH1310663 A CH 1310663A CH 1310663 A CH1310663 A CH 1310663A CH 415663 A CH415663 A CH 415663A
- Authority
- CH
- Switzerland
- Prior art keywords
- group
- alkoxy
- carbon atoms
- hydroxy
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL222701 | 1957-11-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH415663A true CH415663A (de) | 1966-06-30 |
Family
ID=19751044
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1310663A CH415663A (de) | 1957-11-23 | 1958-11-20 | Verfahren zur Herstellung neuer Ester von substituierten, sekundären oder tertiären Aralkylamino-alkoholen mit substituierter Benzoesäure |
| CH6639458A CH386447A (de) | 1957-11-23 | 1958-11-20 | Verfahren zur Herstellung neuer Ester von substituierten, sekundären oder tertiären Aralkylamino-alkoholen mit substituierter Benzoesäure |
| CH1310563A CH398629A (de) | 1957-11-23 | 1958-11-20 | Verfahren zur Herstellung neuer Ester von substituierten sekundären oder tertiären Aralkylamino-alkoholen mit substituierter Benzoesäure |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH6639458A CH386447A (de) | 1957-11-23 | 1958-11-20 | Verfahren zur Herstellung neuer Ester von substituierten, sekundären oder tertiären Aralkylamino-alkoholen mit substituierter Benzoesäure |
| CH1310563A CH398629A (de) | 1957-11-23 | 1958-11-20 | Verfahren zur Herstellung neuer Ester von substituierten sekundären oder tertiären Aralkylamino-alkoholen mit substituierter Benzoesäure |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3265577A (cs) |
| CH (3) | CH415663A (cs) |
| DK (1) | DK104630C (cs) |
| FR (1) | FR1219254A (cs) |
| GB (1) | GB914783A (cs) |
| NL (1) | NL112650C (cs) |
| OA (1) | OA00968A (cs) |
-
0
- NL NL112650D patent/NL112650C/xx active
-
1958
- 1958-11-20 DK DK260361AA patent/DK104630C/da active
- 1958-11-20 CH CH1310663A patent/CH415663A/de unknown
- 1958-11-20 CH CH6639458A patent/CH386447A/de unknown
- 1958-11-20 CH CH1310563A patent/CH398629A/de unknown
- 1958-11-21 FR FR779768A patent/FR1219254A/fr not_active Expired
- 1958-11-23 GB GB37563/58A patent/GB914783A/en not_active Expired
-
1964
- 1964-12-28 OA OA51072A patent/OA00968A/xx unknown
-
1965
- 1965-10-06 US US493568A patent/US3265577A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US3265577A (en) | 1966-08-09 |
| CH386447A (de) | 1965-01-15 |
| FR1219254A (fr) | 1960-05-17 |
| OA00968A (fr) | 1968-08-07 |
| GB914783A (en) | 1963-01-02 |
| DK104630C (da) | 1966-06-13 |
| CH398629A (de) | 1966-03-15 |
| NL112650C (cs) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH415663A (de) | Verfahren zur Herstellung neuer Ester von substituierten, sekundären oder tertiären Aralkylamino-alkoholen mit substituierter Benzoesäure | |
| EP3016925A1 (de) | Verfahren zur herstellung von 3-heptanol aus einer mischung enthaltend 2-ehthylhexanala und 3-heptylformiat | |
| DE910647C (de) | Verfahren zur Herstellung von Oximen | |
| DE2107990C2 (de) | Verfahren zur Herstellung von Formylnitrilderivaten | |
| EP0028375B1 (de) | Verfahren zur Herstellung von Phenylessigsäure und von deren einfachen Derivaten | |
| CH616143A5 (cs) | ||
| DE2218647A1 (de) | Neues verfahren zur herstellung von n-(trans-4-hydroxy-cyclohexyl)-(2-amino3,5-dibrom-benzyl)-amin | |
| DE2640026C2 (de) | Verfahren zur Herstellung von 6,10,14-Trimethylpentadecan-2-on | |
| AT213877B (de) | Verfahren zur Herstellung von neuen basisch substituierten Diphenylalkan-Derivaten und deren Säureadditionssalzen bzw. quartären Ammoniumsalzen | |
| DE3020298C2 (de) | Verfahren zur Herstellung von 2,2,4,5,5-Pentamethyl-3-formyl-3-pyrrolin | |
| AT202564B (de) | Verfahren zur Herstellung von neuen substituierten 3,4,6-Trioxohexahydropyridazinen | |
| DE1618297C3 (de) | Verfahren zur Herstellung von basischen Äthern | |
| DE1018869B (de) | Verfahren zur Herstellung von Aminoalkylpurinderivaten | |
| AT212297B (de) | Verfahren zur Herstellung von neuen Glykolen | |
| DE951630C (de) | Verfahren zur Herstellung von in 20 (22)-Stellung ungesaettigten 22-tertiaer-Aminobisnorcholanen | |
| DE1242241B (de) | Verfahren zur Herstellung von substituierten Phenyl-alpha-aminoketonen und deren Saeureadditionssalzen bzw. deren optischen Antipoden | |
| AT265275B (de) | Verfahren zur Herstellung von 10-Aminoalkyl-5,5-dialkylacridanen und von deren pharmazeutisch verträglichen Salzen | |
| AT233018B (de) | Verfahren zur Herstellung von neuen Iminodibenzylderivaten | |
| DE1293148B (de) | Verfahren zur Herstellung neuer 1-Benzyl-3-isopropyl-carbazinate | |
| DE2166997B2 (de) | Verfahren zur Herstellung von 4,4-Diphenyl-piperidinen | |
| DE3011156A1 (de) | Verfahren zur herstellung von isochinolinderivaten | |
| DE1098510B (de) | Verfahren zur Herstellung von 3-substituierten 1-Benzylindanen | |
| DE2210121B2 (de) | Pyrido eckige Klammer auf 2,3-b eckige Klammer zu indole, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| CH413855A (de) | Verfahren zur Herstellung von neuen a-Amino-B-oxycarbonsäureamiden | |
| DD268244A5 (de) | Verfahren zur herstellung von 5-hydroxydiprafenon und seiner salze mit saeuren |